(Q44320255)

English

Effects of selective cyclooxygenase-2 inhibition on gingival tissue levels of prostaglandin E2 and prostaglandin F2alpha and clinical parameters of chronic periodontitis

scientific article published in January 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Effects of selective cyclooxygenase-2 inhibition on gingival tissue levels of prostaglandin E2 and prostaglandin F2alpha and clinical parameters of chronic periodontitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

0 references

chronic periodontitis

1 reference

based on heuristic

inferred from title

prostaglandin E2

1 reference

based on heuristic

inferred from title

author name string

Saynur Vardar

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Haluk Baylas

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Afig Huseyinov

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Journal of Periodontology

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

74

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

57-63

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Inhibition of alveolar bone loss in beagles with the NSAID naproxen

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease.

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Cyclooxygenase-2 specificity and its clinical implications

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

The clinical potential of cyclooxygenase-2-specific inhibitors

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Differentiating among nonsteroidal antiinflammatory drugsby pharmacokinetic and pharmacodynamic profiles

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Host modulation as a therapeutic strategy in the treatment of periodontal disease

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Periodontal diseases: pathogenesis

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Modulation of host PGE2 secretion as a determinant of periodontal disease expression

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Prostaglandin E2 levels and human periodontal disease

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Prostaglandin F2alpha upregulates interleukin-6 production in human gingival fibroblasts

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Upregulation of matrix metalloproteinase-1 production by prostaglandin F2alpha in human gingival fibroblasts

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Healing of the Oral Mucosa with the Use of Collagen Artificial Skin

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Nonsteroidal antiinflammatory drugs as inhibitors of periodontal disease progression

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Assessment of the efficacy of a nonsteroidal anti-inflammatory drug, Naprosyn, in the treatment of gingivitis

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Blocking periodontal disease progression with anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Prostaglandins, Arachidonic Acid, and Inflammation

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Mechanism of action of aspirin-like drugs

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Effects of flurbiprofen on the progression of periodontitis in Macaca mulatta

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Flurbiprofen treatment of human periodontitis: effect on alveolar bone height and metabolism

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Effects of NSAIDs on beagle crevicular cyclooxygenase metabolites and periodontal bone loss

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Interleukin-1 beta, prostaglandin E2, and immunoglobulin G subclasses in gingival crevicular fluid in patients undergoing periodontal therapy

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Reversed-phase high-pressure liquid chromatography of arachidonic acid metabolites formed by cyclooxygenase and lipoxygenases

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2003.74.1.57

21 January 2018

Identifiers

10.1902/JOP.2003.74.1.57

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44320255&oldid=2109417807"